CSN5-IN-2
Product Specifications
Target
DNA/RNA Synthesis, PD-1/PD-L1
Related Pathways
Immunology/Inflammation, DNA Damage/DNA Repair, Cell Cycle/Checkpoint, Apoptosis
Bioactivity
CSN5-IN-2 (Compound 31) is a CSN5 inhibitor with an IC50 of 0.36 μM. It increases Cullin 1 neddylation levels in cancer cells and downregulates the expression of RAD51 and PD-L1. CSN5-IN-2 exhibits antitumor activity, which is enhanced when used in combination with Talazoparib.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog